Estimating teh costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015
- 1 January 2008
- journal article
- research article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 86 (1), 27-39
- https://doi.org/10.2471/blt.07.045096
Abstract
Objective To estimate the cost of scaling up childhood immunization services required to reach the WHO-UNICEF Global Immunization Vision and Strategy (GIVS) goal of reducing mortality due to vaccine-preventable diseases by two-thirds by 2015. Methods A model was developed to estimate the total cost of reaching GIVS goals by 2015 in 117 low- and lower-middle-income countries. Current spending was estimated by analysing data from country planning documents, and scale-up costs were estimated using a bottom-up, ingredients-based approach. Financial costs were estimated by country and year for reaching 90% coverage with all existing vaccines; introducing a discrete set of new vaccines (rotavirus, conjugate pneumococcal, conjugate meningococcal A and Japanese encephalitis); and conducting immunization campaigns to protect at-risk populations against polio, tetanus, measles, yellow fever and meningococcal meningitis. Findings The 72 poorest countries of the world spent US$ 2.5 (range: US$ 1.8-4.2) billion on immunization in 2005, an increase from US$ 1.1 (range: US$ 0.9-1.6) billion in 2000. By 2015 annual immunization costs will on average increase to about US$ 4.0 (range US$ 2.9-6.7) billion. Total immunization costs for 2006-2015 are estimated at US$ 35 (range US$ 13-40) billion; of this, US$ 16.2 billion are incremental costs, comprised of US$ 5.6 billion for system scale-up and US$ 8.7 billion for vaccines; US$ 19.3 billion is required to maintain immunization programmes at 2005 levels. In all 117 low- and lower-middle-income countries, total costs for 2006-2015 are estimated at US$ 76 (range: US$ 23-110) billion, with US$ 49 billion for maintaining current systems and $27 billion for scaling-up. Conclusion In the 72 poorest countries, US$ 11-15 billion (30%-40%) of the overall resource needs are unmet if the GIVS goals are to be reached. The methods developed in this paper are approximate estimates with limitations, but provide a roadmap of financing gaps that need to be filled to scale up immunization by 2015.
Keywords
This publication has 14 references indexed in Scilit:
- The Value of VaccinationAdvances in experimental medicine and biology, 2010
- Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessmentThe Lancet, 2006
- A new global immunisation vision and strategyThe Lancet, 2006
- Economic Evaluation of Measles Catch-Up and Follow-Up Campaigns in Afghanistan in 2002 and 2003Disasters, 2006
- Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing programThe International Journal of Health Planning and Management, 2006
- Economic analysis of the 1996–1997 mass measles immunization campaigns in South AfricaVaccine, 2004
- Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan.2004
- Financial challenges of immunization: a look at GAVI.2004
- Constraints to expanding access to health interventions: an empirical analysis and country typologyJournal of International Development, 2003
- Introducing GAVI and the Global Fund for Children’s VaccinesVaccine, 2000